Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction
White blood cell (WBC) count and high-sensitive C-reactive protein (hs-CRP) are both used as markers of inflammation and prognosis after an ST elevation myocardial infarction (STEMI), but it is unknown whether they have independent prognostic value. We investigated the association and independent pr...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2008-02, Vol.101 (4), p.446-451 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 451 |
|---|---|
| container_issue | 4 |
| container_start_page | 446 |
| container_title | The American journal of cardiology |
| container_volume | 101 |
| creator | Smit, Jaap Jan J., MD Ottervanger, Jan Paul, MD, PhD Slingerland, Robbert J., MD, PhD Kolkman, J.J. Evelien, MSc Suryapranata, Harry, MD, PhD Hoorntje, Jan C.A., MD, PhD Dambrink, Jan-Henk E., MD, PhD Gosselink, A.T. Marcel, MD, PhD de Boer, Menko-Jan, MD, PhD Zijlstra, Felix, MD, PhD van ’t Hof, Arnoud W.J., MD, PhD |
| description | White blood cell (WBC) count and high-sensitive C-reactive protein (hs-CRP) are both used as markers of inflammation and prognosis after an ST elevation myocardial infarction (STEMI), but it is unknown whether they have independent prognostic value. We investigated the association and independent prognostic importance of WBC and hs-CRP after STEMI. In this subanalysis of the On-TIME trial, in 490 of 507 (97%) patients, either WBC count or CRP, and in 362 (71%) patients, both WBC count and CRP, were measured on admission before primary percutaneous coronary intervention. There was no significant correlation between WBC count and CRP (R = 0.080). Higher levels of CRP were associated with a reinfarction or death within 1 year (mean hs-CRP 14.2 ± 20.4 vs 6.1 ± 14.2, p = 0.006), but CRP was not associated with enzymatic infarct size (lactate dehydrogenase, LDHQ48) or left ventricular ejection fraction. A higher baseline WBC count was associated with larger LDHQ48 and lower left ventricular ejection fraction but not with 1-year reinfarction or death. In conclusion, although both WBC count and CRP are markers of inflammation and predictors of outcome after STEMI, we did not find a correlation between baseline WBC count and CRP levels in patients treated with primary percutaneous coronary intervention for STEMI. The mechanisms by which WBC counts predict outcome were related to myocardial infarct size whereas CRP were not. |
| doi_str_mv | 10.1016/j.amjcard.2007.09.088 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70350461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914907020280</els_id><sourcerecordid>1428899851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-4ab853e796b78209071cef0a07a3e4ca7d6234015b22939324c707c13abd751f3</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEokvhEUAWEtyyjO1knVxAJSpQqaiV2sLRcpyJ8JLYi-2stE_G6-GwUZF64WTN6PPv-f1Plr2ksKZAN--2azVutfLdmgGINdRrqKpH2YpWos5pTfnjbAUALK9pUZ9kz0LYppLScvM0O6EVp0yU5Sr73bhxp7wJzhLXk7uA_TRYDGGumtyj0tHskVx7F9FY8g19mAL5_sNEJB8H5zrS4DCQxk02kugSiJ3RkVxNUbsRyVkf0aeuGZU_kGv0eorKoksijfPOzt0Lm5g92mjSFL3z5OaWnA-4V38bXw9u9mnUkMBeeT13n2dPejUEfLGcp9ndp_Pb5kt-efX5ojm7zHVZ0JgXqq1KjqLetKJiUIOgGntQIBTHQivRbRgvgJYtYzWvOSu0AKEpV20nStrz0-ztUXfn3a8JQ5SjCTo5PnqQAngJxYYm8PUDcOsmb9NsknHgomSUJ6g8Qtq7EDz2cnf8GElBzrHKrVxilXOsEmqZYk33Xi3iUzti9-_WkmMC3iyACloNvVdWm3DPJa0qGZ25D0cO05_tDXoZtEGrU2YedZSdM_8d5f0DBT0Ya9KjP_GA4d40lYFJkDfzDs4rCAIYsAr4H7XE2gc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230375213</pqid></control><display><type>article</type><title>Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Smit, Jaap Jan J., MD ; Ottervanger, Jan Paul, MD, PhD ; Slingerland, Robbert J., MD, PhD ; Kolkman, J.J. Evelien, MSc ; Suryapranata, Harry, MD, PhD ; Hoorntje, Jan C.A., MD, PhD ; Dambrink, Jan-Henk E., MD, PhD ; Gosselink, A.T. Marcel, MD, PhD ; de Boer, Menko-Jan, MD, PhD ; Zijlstra, Felix, MD, PhD ; van ’t Hof, Arnoud W.J., MD, PhD</creator><creatorcontrib>Smit, Jaap Jan J., MD ; Ottervanger, Jan Paul, MD, PhD ; Slingerland, Robbert J., MD, PhD ; Kolkman, J.J. Evelien, MSc ; Suryapranata, Harry, MD, PhD ; Hoorntje, Jan C.A., MD, PhD ; Dambrink, Jan-Henk E., MD, PhD ; Gosselink, A.T. Marcel, MD, PhD ; de Boer, Menko-Jan, MD, PhD ; Zijlstra, Felix, MD, PhD ; van ’t Hof, Arnoud W.J., MD, PhD ; On-TIME Study Group</creatorcontrib><description>White blood cell (WBC) count and high-sensitive C-reactive protein (hs-CRP) are both used as markers of inflammation and prognosis after an ST elevation myocardial infarction (STEMI), but it is unknown whether they have independent prognostic value. We investigated the association and independent prognostic importance of WBC and hs-CRP after STEMI. In this subanalysis of the On-TIME trial, in 490 of 507 (97%) patients, either WBC count or CRP, and in 362 (71%) patients, both WBC count and CRP, were measured on admission before primary percutaneous coronary intervention. There was no significant correlation between WBC count and CRP (R = 0.080). Higher levels of CRP were associated with a reinfarction or death within 1 year (mean hs-CRP 14.2 ± 20.4 vs 6.1 ± 14.2, p = 0.006), but CRP was not associated with enzymatic infarct size (lactate dehydrogenase, LDHQ48) or left ventricular ejection fraction. A higher baseline WBC count was associated with larger LDHQ48 and lower left ventricular ejection fraction but not with 1-year reinfarction or death. In conclusion, although both WBC count and CRP are markers of inflammation and predictors of outcome after STEMI, we did not find a correlation between baseline WBC count and CRP levels in patients treated with primary percutaneous coronary intervention for STEMI. The mechanisms by which WBC counts predict outcome were related to myocardial infarct size whereas CRP were not.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2007.09.088</identifier><identifier>PMID: 18312755</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Age Factors ; Aged ; Angioplasty, Balloon, Coronary ; Biological and medical sciences ; Biomarkers - blood ; C-Reactive Protein - analysis ; Cardiology. Vascular system ; Cardiovascular ; Clinical outcomes ; Comparative analysis ; Coronary heart disease ; Diseases of the cardiovascular system ; Double-Blind Method ; Female ; Heart ; Heart attacks ; Humans ; Hypotension - epidemiology ; L-Lactate Dehydrogenase - blood ; Leukocyte Count ; Leukocytes ; Male ; Medical sciences ; Medical treatment ; Multivariate Analysis ; Myocardial Infarction - blood ; Myocardial Infarction - mortality ; Myocardial Infarction - therapy ; Myocarditis. Cardiomyopathies ; Prospective Studies ; Proteins ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Recurrence ; Stroke Volume</subject><ispartof>The American journal of cardiology, 2008-02, Vol.101 (4), p.446-451</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Feb 15, 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-4ab853e796b78209071cef0a07a3e4ca7d6234015b22939324c707c13abd751f3</citedby><cites>FETCH-LOGICAL-c541t-4ab853e796b78209071cef0a07a3e4ca7d6234015b22939324c707c13abd751f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914907020280$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20086235$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18312755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smit, Jaap Jan J., MD</creatorcontrib><creatorcontrib>Ottervanger, Jan Paul, MD, PhD</creatorcontrib><creatorcontrib>Slingerland, Robbert J., MD, PhD</creatorcontrib><creatorcontrib>Kolkman, J.J. Evelien, MSc</creatorcontrib><creatorcontrib>Suryapranata, Harry, MD, PhD</creatorcontrib><creatorcontrib>Hoorntje, Jan C.A., MD, PhD</creatorcontrib><creatorcontrib>Dambrink, Jan-Henk E., MD, PhD</creatorcontrib><creatorcontrib>Gosselink, A.T. Marcel, MD, PhD</creatorcontrib><creatorcontrib>de Boer, Menko-Jan, MD, PhD</creatorcontrib><creatorcontrib>Zijlstra, Felix, MD, PhD</creatorcontrib><creatorcontrib>van ’t Hof, Arnoud W.J., MD, PhD</creatorcontrib><creatorcontrib>On-TIME Study Group</creatorcontrib><title>Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>White blood cell (WBC) count and high-sensitive C-reactive protein (hs-CRP) are both used as markers of inflammation and prognosis after an ST elevation myocardial infarction (STEMI), but it is unknown whether they have independent prognostic value. We investigated the association and independent prognostic importance of WBC and hs-CRP after STEMI. In this subanalysis of the On-TIME trial, in 490 of 507 (97%) patients, either WBC count or CRP, and in 362 (71%) patients, both WBC count and CRP, were measured on admission before primary percutaneous coronary intervention. There was no significant correlation between WBC count and CRP (R = 0.080). Higher levels of CRP were associated with a reinfarction or death within 1 year (mean hs-CRP 14.2 ± 20.4 vs 6.1 ± 14.2, p = 0.006), but CRP was not associated with enzymatic infarct size (lactate dehydrogenase, LDHQ48) or left ventricular ejection fraction. A higher baseline WBC count was associated with larger LDHQ48 and lower left ventricular ejection fraction but not with 1-year reinfarction or death. In conclusion, although both WBC count and CRP are markers of inflammation and predictors of outcome after STEMI, we did not find a correlation between baseline WBC count and CRP levels in patients treated with primary percutaneous coronary intervention for STEMI. The mechanisms by which WBC counts predict outcome were related to myocardial infarct size whereas CRP were not.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Angioplasty, Balloon, Coronary</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>C-Reactive Protein - analysis</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Clinical outcomes</subject><subject>Comparative analysis</subject><subject>Coronary heart disease</subject><subject>Diseases of the cardiovascular system</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Hypotension - epidemiology</subject><subject>L-Lactate Dehydrogenase - blood</subject><subject>Leukocyte Count</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Multivariate Analysis</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - mortality</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Prospective Studies</subject><subject>Proteins</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Recurrence</subject><subject>Stroke Volume</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksFu1DAQhiMEokvhEUAWEtyyjO1knVxAJSpQqaiV2sLRcpyJ8JLYi-2stE_G6-GwUZF64WTN6PPv-f1Plr2ksKZAN--2azVutfLdmgGINdRrqKpH2YpWos5pTfnjbAUALK9pUZ9kz0LYppLScvM0O6EVp0yU5Sr73bhxp7wJzhLXk7uA_TRYDGGumtyj0tHskVx7F9FY8g19mAL5_sNEJB8H5zrS4DCQxk02kugSiJ3RkVxNUbsRyVkf0aeuGZU_kGv0eorKoksijfPOzt0Lm5g92mjSFL3z5OaWnA-4V38bXw9u9mnUkMBeeT13n2dPejUEfLGcp9ndp_Pb5kt-efX5ojm7zHVZ0JgXqq1KjqLetKJiUIOgGntQIBTHQivRbRgvgJYtYzWvOSu0AKEpV20nStrz0-ztUXfn3a8JQ5SjCTo5PnqQAngJxYYm8PUDcOsmb9NsknHgomSUJ6g8Qtq7EDz2cnf8GElBzrHKrVxilXOsEmqZYk33Xi3iUzti9-_WkmMC3iyACloNvVdWm3DPJa0qGZ25D0cO05_tDXoZtEGrU2YedZSdM_8d5f0DBT0Ya9KjP_GA4d40lYFJkDfzDs4rCAIYsAr4H7XE2gc</recordid><startdate>20080215</startdate><enddate>20080215</enddate><creator>Smit, Jaap Jan J., MD</creator><creator>Ottervanger, Jan Paul, MD, PhD</creator><creator>Slingerland, Robbert J., MD, PhD</creator><creator>Kolkman, J.J. Evelien, MSc</creator><creator>Suryapranata, Harry, MD, PhD</creator><creator>Hoorntje, Jan C.A., MD, PhD</creator><creator>Dambrink, Jan-Henk E., MD, PhD</creator><creator>Gosselink, A.T. Marcel, MD, PhD</creator><creator>de Boer, Menko-Jan, MD, PhD</creator><creator>Zijlstra, Felix, MD, PhD</creator><creator>van ’t Hof, Arnoud W.J., MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080215</creationdate><title>Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction</title><author>Smit, Jaap Jan J., MD ; Ottervanger, Jan Paul, MD, PhD ; Slingerland, Robbert J., MD, PhD ; Kolkman, J.J. Evelien, MSc ; Suryapranata, Harry, MD, PhD ; Hoorntje, Jan C.A., MD, PhD ; Dambrink, Jan-Henk E., MD, PhD ; Gosselink, A.T. Marcel, MD, PhD ; de Boer, Menko-Jan, MD, PhD ; Zijlstra, Felix, MD, PhD ; van ’t Hof, Arnoud W.J., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-4ab853e796b78209071cef0a07a3e4ca7d6234015b22939324c707c13abd751f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Angioplasty, Balloon, Coronary</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>C-Reactive Protein - analysis</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Clinical outcomes</topic><topic>Comparative analysis</topic><topic>Coronary heart disease</topic><topic>Diseases of the cardiovascular system</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Hypotension - epidemiology</topic><topic>L-Lactate Dehydrogenase - blood</topic><topic>Leukocyte Count</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Multivariate Analysis</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - mortality</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Prospective Studies</topic><topic>Proteins</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Recurrence</topic><topic>Stroke Volume</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smit, Jaap Jan J., MD</creatorcontrib><creatorcontrib>Ottervanger, Jan Paul, MD, PhD</creatorcontrib><creatorcontrib>Slingerland, Robbert J., MD, PhD</creatorcontrib><creatorcontrib>Kolkman, J.J. Evelien, MSc</creatorcontrib><creatorcontrib>Suryapranata, Harry, MD, PhD</creatorcontrib><creatorcontrib>Hoorntje, Jan C.A., MD, PhD</creatorcontrib><creatorcontrib>Dambrink, Jan-Henk E., MD, PhD</creatorcontrib><creatorcontrib>Gosselink, A.T. Marcel, MD, PhD</creatorcontrib><creatorcontrib>de Boer, Menko-Jan, MD, PhD</creatorcontrib><creatorcontrib>Zijlstra, Felix, MD, PhD</creatorcontrib><creatorcontrib>van ’t Hof, Arnoud W.J., MD, PhD</creatorcontrib><creatorcontrib>On-TIME Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smit, Jaap Jan J., MD</au><au>Ottervanger, Jan Paul, MD, PhD</au><au>Slingerland, Robbert J., MD, PhD</au><au>Kolkman, J.J. Evelien, MSc</au><au>Suryapranata, Harry, MD, PhD</au><au>Hoorntje, Jan C.A., MD, PhD</au><au>Dambrink, Jan-Henk E., MD, PhD</au><au>Gosselink, A.T. Marcel, MD, PhD</au><au>de Boer, Menko-Jan, MD, PhD</au><au>Zijlstra, Felix, MD, PhD</au><au>van ’t Hof, Arnoud W.J., MD, PhD</au><aucorp>On-TIME Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2008-02-15</date><risdate>2008</risdate><volume>101</volume><issue>4</issue><spage>446</spage><epage>451</epage><pages>446-451</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>White blood cell (WBC) count and high-sensitive C-reactive protein (hs-CRP) are both used as markers of inflammation and prognosis after an ST elevation myocardial infarction (STEMI), but it is unknown whether they have independent prognostic value. We investigated the association and independent prognostic importance of WBC and hs-CRP after STEMI. In this subanalysis of the On-TIME trial, in 490 of 507 (97%) patients, either WBC count or CRP, and in 362 (71%) patients, both WBC count and CRP, were measured on admission before primary percutaneous coronary intervention. There was no significant correlation between WBC count and CRP (R = 0.080). Higher levels of CRP were associated with a reinfarction or death within 1 year (mean hs-CRP 14.2 ± 20.4 vs 6.1 ± 14.2, p = 0.006), but CRP was not associated with enzymatic infarct size (lactate dehydrogenase, LDHQ48) or left ventricular ejection fraction. A higher baseline WBC count was associated with larger LDHQ48 and lower left ventricular ejection fraction but not with 1-year reinfarction or death. In conclusion, although both WBC count and CRP are markers of inflammation and predictors of outcome after STEMI, we did not find a correlation between baseline WBC count and CRP levels in patients treated with primary percutaneous coronary intervention for STEMI. The mechanisms by which WBC counts predict outcome were related to myocardial infarct size whereas CRP were not.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18312755</pmid><doi>10.1016/j.amjcard.2007.09.088</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2008-02, Vol.101 (4), p.446-451 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70350461 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Age Factors Aged Angioplasty, Balloon, Coronary Biological and medical sciences Biomarkers - blood C-Reactive Protein - analysis Cardiology. Vascular system Cardiovascular Clinical outcomes Comparative analysis Coronary heart disease Diseases of the cardiovascular system Double-Blind Method Female Heart Heart attacks Humans Hypotension - epidemiology L-Lactate Dehydrogenase - blood Leukocyte Count Leukocytes Male Medical sciences Medical treatment Multivariate Analysis Myocardial Infarction - blood Myocardial Infarction - mortality Myocardial Infarction - therapy Myocarditis. Cardiomyopathies Prospective Studies Proteins Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Recurrence Stroke Volume |
| title | Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A14%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Usefulness%20of%20C-reactive%20Protein%20Versus%20White%20Blood%20Cell%20Count%20to%20Predict%20Outcome%20After%20Primary%20Percutaneous%20Coronary%20Intervention%20for%20ST%20Elevation%20Myocardial%20Infarction&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Smit,%20Jaap%20Jan%20J.,%20MD&rft.aucorp=On-TIME%20Study%20Group&rft.date=2008-02-15&rft.volume=101&rft.issue=4&rft.spage=446&rft.epage=451&rft.pages=446-451&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2007.09.088&rft_dat=%3Cproquest_cross%3E1428899851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230375213&rft_id=info:pmid/18312755&rft_els_id=1_s2_0_S0002914907020280&rfr_iscdi=true |